Monoclonal antibody passive experimental autoimmune myasthenia gravis: current progress and future directions
{{output}}
Experimental Autoimmune Myasthenia Gravis (EAMG) remains a cornerstone platform for mechanistic studies of pathogenic antibodies in myasthenia gravis (MG). In particular, monoclonal antibody passive-transfer EAMG (mAb-PTMG) has been instrumental in establishin... ...
